Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary）

Recruiting now

Conditions studied: Urologic Cancer

In brief

This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims to explore the relationship between the imaging information of urologic cancer patients, tumor microenvironment and the prognosis of urologic cancer patients.

Key facts

Study ID

NCT06537037

Run by

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

People needed

150

Starts

2024-08-01

Expected to finish

2027-08-01

Last updated by the study team

2024-08-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients treated for urologic cancer in Wuhan Union Hospital from August 2024 to August 2027;
• Aged > 18 years old;
• At least one CT scan or MRI scan before treatment;
• Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
• Exclusion criteria：
• Poor image quality;
• Incomplete clinical data or loss of follow-up;
• Presence of another primary malignancy other than urologic cancer;
• Unclear pathological diagnosis。

Where it is running

• Union Hospital，Tongji Medical College，Huazhong University of Science and Technology — Wuhan, Hubei, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.